Vaccine Protects Goats from Herpesvirus Infection
Author Information
Author(s): Thiry Julien, Tempesta Maria, Camero Michele, Tarsitano Elvira, Muylkens Benoît, Meurens François, Thiry Etienne, Buonavoglia Canio
Primary Institution: Department of Animal Health and Well-being, Faculty of Veterinary Medicine, University of Bari, Italy
Hypothesis
Can an intranasal administration of a bovine vaccine afford protection against clinical genital infection in goats?
Conclusion
The intranasal application of a live attenuated gE-negative BoHV-1 vaccine provides clinical protection and reduces virus excretion in goats challenged by a CpHV-1 genital infection.
Supporting Evidence
- The vaccine did not induce any undesirable local or systemic reaction.
- Immunised goats showed a significant reduction in disease severity after challenge.
- Antibodies neutralising both BoHV-1 and CpHV-1 were raised in immunised goats.
- Goats immunised with gE-negative BoHV-1 exhibited a significant reduction in the length and peak of viral excretion.
Takeaway
The study shows that a vaccine given through the nose can help protect goats from getting sick from a specific virus that can cause problems in their private parts.
Methodology
Nine goats were divided into three groups, with two groups receiving intranasal vaccinations and all groups challenged intravaginally with a virulent strain of CpHV-1.
Limitations
The study had a relatively low number of animals, which may affect the power of the statistical tests.
Participant Demographics
Nine dairy Alpine, Ionica, Maltese, and Saanen crossbred goats, approximately 4–5 years of age.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website